South African vaccine adviser backs Pfizer shot after study

  • Reuters
  • Stock Market News
South African vaccine adviser backs Pfizer shot after study
Credit: © Reuters.

JOHANNESBURG, Feb 19 (Reuters) - One of the South African government's top advisers on COVID-19 vaccines said on Friday that the Pfizer-BioNTech PFE (NYSE: PFE ).N 22UAy.DE shot was "still a very good vaccine," despite a study showing the dominant local virus variant may reduce protective antibodies elicited by it.

Barry Schoub, chairman of the Ministerial Advisory Committee on vaccines, told Reuters that the two-thirds reduction in protective antibodies mentioned in the study "means there is quite a significant remnant neutralising potency".

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100